Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wujin Chen

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Frontiers in Endocrinology|January 1, 2026
Diabetes as an independent risk factor for severe inflammatory bowel disease: evidence from an inflammation-metabolism-liver coupling frameworkBin Huang, Honglin An, Liming Chen, et al.
Hereditas|August 29, 2025
Qingxie Fuzheng granules attenuate cancer cachexia by restoring gut microbiota homeostasis and suppressing IL-6/NF-κB signaling in colorectal adenocarcinomaYishun Jin, Lisha Lu, Hangju Hua, et al.
Research (Washington, D.C.)|October 23, 2025
Chronic Psychological Stress in Oncogenesis: Multisystem Crosstalk and Multimodal InterventionsBin Huang, Honglin An, Han Wu, et al.
Frontiers in Oncology|September 26, 2022
Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancerShen Zhao, Liyu Su, Yigui Chen, et al.
Frontiers in Endocrinology|October 14, 2022
Diagnostic model for predicting hyperuricemia based on alterations of the gut microbiome in individuals with different serum uric acid levelsMeiting Liang, Jingkun Liu, Wujin Chen, et al.
The Oncologist|June 14, 2020
Apatinib plus Chemotherapy as a Second-Line Treatment in Unresectable Non-Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical TrialZongyang Yu, Xiuyu Cai, Zhengwu Xu, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Frontiers in Endocrinology|January 1, 2026
Diabetes as an independent risk factor for severe inflammatory bowel disease: evidence from an inflammation-metabolism-liver coupling frameworkBin Huang, Honglin An, Liming Chen, et al.
Hereditas|August 29, 2025
Qingxie Fuzheng granules attenuate cancer cachexia by restoring gut microbiota homeostasis and suppressing IL-6/NF-κB signaling in colorectal adenocarcinomaYishun Jin, Lisha Lu, Hangju Hua, et al.
Research (Washington, D.C.)|October 23, 2025
Chronic Psychological Stress in Oncogenesis: Multisystem Crosstalk and Multimodal InterventionsBin Huang, Honglin An, Han Wu, et al.
Frontiers in Oncology|September 26, 2022
Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancerShen Zhao, Liyu Su, Yigui Chen, et al.
Frontiers in Endocrinology|October 14, 2022
Diagnostic model for predicting hyperuricemia based on alterations of the gut microbiome in individuals with different serum uric acid levelsMeiting Liang, Jingkun Liu, Wujin Chen, et al.
The Oncologist|June 14, 2020
Apatinib plus Chemotherapy as a Second-Line Treatment in Unresectable Non-Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical TrialZongyang Yu, Xiuyu Cai, Zhengwu Xu, et al.
Pageof 3